News

Phase 3 Clinical Study Of Mazdutide In Chinese Adults With Overweight Or Obesity (GLORY-1) Published In The New England Journal Of Medicine (NEJM)
GLORY-3: A Phase 3 trial comparing mazdutide and semaglutide in Chinese participants with overweight/obesity and metabolic dysfunction-associated fatty liver disease (MAFLD). DREAMS-1: A Phase 3 trial ...